Correction to: Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials. . Circulation 2022;145:e641.

Read + Share

Amedeo Smart

Independent Medical Education